Skip to content
The Policy VaultThe Policy Vault

Lenvima (lenvatinib capsules) — Cigna

Thyroid Carcinoma, Anaplastic

Initial criteria

  • Patient is age ≥ 18 years
  • Medication is used in combination with Keytruda (pembrolizumab intravenous injection)

Approval duration

1 year